![](/img/cover-not-exists.png)
Sofosbuvir–velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India
Sood, Ajit, Duseja, Ajay, Kabrawala, Mayank, Amrose, Pradeep, Goswami, Bhadadev, Chowdhury, Abhijit, Sarin, Shiv Kumar, Koshy, Abraham, Hyland, Robert H., Lu, Sophia, Camus, Gregory, Stamm, Luisa M.,Language:
english
Journal:
Hepatology International
DOI:
10.1007/s12072-019-09927-6
Date:
February, 2019
File:
PDF, 370 KB
english, 2019